Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: A Survey Study

References

• World Health Organization. WHO Coronavirus (COVID-19) Dashboard. [cited 2022 May 26]; Available from: https://covid19.who.int.
   Google Scholar
• CDC. People with Certain Medical Conditions. Centers for Disease Control and Prevention 2022. [cited 2022 May 26]; Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html.
   Google Scholar
• Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615. doi:10.1056/NEJMoa2034577.
   Google Scholar
• Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–416. doi:10.1056/NEJMoa2035389.
   PubMed Web of Science ®Google Scholar
• Sadoff J, Le Gars M, Shukarev G, Heerwegh D, Truyers C, de Groot AM, et al. Interim results of a phase 1–2a trial of Ad26.COV2.S covid-19 vaccine. N Engl J Med. 2021;384(19):1824–1835. [cited 2022 May 26]; Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2034201.
   Web of Science ®Google Scholar
• CDC. COVID-19 Vaccinations in the United States. Centers for Disease Control and Prevention 2020. [cited 2022 May 26]; Available from: https://covid.cdc.gov/covid-data-tracker.
   Google Scholar
• CDC. Trends in number of COVID-19 cases and deaths in the US reported to CDC, by State/Territory. Centers for Disease Control and Prevention 2020. [cited 2022 May 26]; Available from: https://covid.cdc.gov/covid-data-tracker.
   Google Scholar
• Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381. doi:10.1016/j.jbi.2008.08.010.
   PubMed Web of Science ®Google Scholar
• Muñana C, Hamel L, Kirzinger A, Brodie M. KFF COVID-19 vaccine monitor: December 2020. KFF 2020. [cited 2022 May 26]; Available from: https://www.kff.org/coronavirus-covid-19/report/kff-covid-19-vaccine-monitor-december-2020/.
   Google Scholar
• Conti R, Akesson J, Weiss E, Sae-Hau M, Lee M, Gracia G, et al. COVID-19 vaccine hesitancy among blood cancer patients. Leuk Lymphoma Soc. [cited 2022 May 26]. Available from: https://www.lls.org/research/covid-19-vaccine-hesitancy-among-blood-cancer-patients.
   Google Scholar
• Nguyen KH, Srivastav A, Razzaghi H, Williams W, Lindley MC, Jorgensen C, et al. COVID-19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination – United States, September and December 2020. MMWR Morb Mortal Wkly Rep. 2021;70:217–222. [cited 2022 May 26]; Available from: https://www.cdc.gov/mmwr/volumes/70/wr/mm7006e3.htm.
   PubMed Web of Science ®Google Scholar
• Szilagyi PG, Thomas K, Shah MD, Vizueta N, Cui Y, Vangala S, et al. National trends in the US public’s likelihood of getting a COVID-19 vaccine—April 1 to December 8, 2020. Jama. 2021;325(4):396–398. doi:10.1001/jama.2020.26419.
   Web of Science ®Google Scholar
• Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health. 2021;6(4):e210–e221. [cited 2022 May 26]; Available from: https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(21)00012-8/fulltext. doi:10.1016/S2468-2667(21)00012-8.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JBW. The patient health questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284–1292. doi:10.1097/01.MLR.0000093487.78664.3C.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JBW, Monahan PO, Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317–325. doi:10.7326/0003-4819-146-5-200703060-00004.
   PubMed Web of Science ®Google Scholar
• Arroll B, Goodyear-Smith F, Crengle S, Gunn J, Kerse N, Fishman T, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med. 2010;8(4):348–353. doi:10.1370/afm.1139.
   PubMed Web of Science ®Google Scholar
• Linardou H, Spanakis N, Koliou G-A, Christopoulou A, Karageorgopoulou S, Alevra N, et al. Responses to SARS-CoV-2 vaccination in patients with cancer (ReCOVer study): a prospective cohort study of the Hellenic Cooperative Oncology Group. Cancers. 2021;13(18):4621. doi:10.3390/cancers13184621.
   PubMed Web of Science ®Google Scholar
• Shmueli ES, Itay A, Margalit O, Berger R, Halperin S, Jurkowicz M, et al. Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study. Eur J Cancer. 2021;157:124–131. doi:10.1016/j.ejca.2021.08.007.
   PubMed Web of Science ®Google Scholar
• Agbarya A, Sarel I, Ziv-Baran T, Agranat S, Schwartz O, Shai A, et al. Efficacy of the mRNA-based BNT162b2 COVID-19 vaccine in patients with solid malignancies treated with anti-neoplastic drugs. Cancers. 2021;13(16):4191. doi:10.3390/cancers13164191.
   PubMed Web of Science ®Google Scholar
• Ligumsky H, Safadi E, Etan T, Vaknin N, Waller M, Croll A, et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine among actively treated cancer patients. J Natl Cancer Inst. 2022;114(2):203–209. doi:10.1093/jnci/djab174.
   PubMedGoogle Scholar
• Barrière J, Chamorey E, Adjtoutah Z, Castelnau O, Mahamat A, Marco S, et al. Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors. Ann Oncol. 2021;32(8):1053–1055. doi:10.1016/j.annonc.2021.04.019.
   PubMed Web of Science ®Google Scholar
• Becerril-Gaitan A, Vaca-Cartagena BF, Ferrigno AS, Mesa-Chavez F, Barrientos-Gutiérrez T, Tagliamento M, et al. Immunogenicity and risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection after coronavirus disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis. Eur J Cancer. 2022;160:243–260. doi:10.1016/j.ejca.2021.10.014.
   PubMed Web of Science ®Google Scholar
• Mair MJ, Berger JM, Berghoff AS, Starzer AM, Ortmayr G, Puhr HC, et al. Humoral immune response in hematooncological patients and health care workers who received SARS-CoV-2 vaccinations. JAMA Oncol. 2022;8(1):106–113. doi:10.1001/jamaoncol.2021.5437.
   PubMed Web of Science ®Google Scholar
• Monin L, Laing AG, Muñoz-Ruiz M, McKenzie DR, Del Molino Del Barrio I, Alaguthurai T, et al. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Lancet Oncol. 2021;22(6):765–778. doi:10.1016/S1470-2045(21)00213-8.
   PubMed Web of Science ®Google Scholar
• Embi PJ, Levy ME, Naleway AL, Patel P, Gaglani M, Natarajan K, et al. Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults – nine states, January–September 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1553–1559. [cited 2022 May 26]; Available from: https://www.cdc.gov/mmwr/volumes/70/wr/mm7044e3.htm.
   PubMed Web of Science ®Google Scholar
• Khubchandani J, Sharma S, Price JH, Wiblishauser MJ, Sharma M, Webb FJ. COVID-19 vaccination hesitancy in the United States: a rapid national assessment. J Community Health. 2021;46(2):270–277. doi:10.1007/s10900-020-00958-x.
   PubMed Web of Science ®Google Scholar
• Moujaess E, Zeid NB, Samaha R, Sawan J, Kourie H, Labaki C, et al. Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey. Future Oncol. 2021;17(31):4071–4079. doi:10.2217/fon-2021-0265.
   PubMed Web of Science ®Google Scholar
• Iscan G, Cetin B, Kilic F, Kalayci H, Kalayci A, Iscan SC. Investigation of anxiety sensitivity levels of cancer patients in terms of COVID-19 vaccine: a cross-sectional study. Support Care Cancer. 2022;30(5):4139–4147. doi:10.1007/s00520-021-06750-4.
   PubMed Web of Science ®Google Scholar
• Büssing A, Hübner J, Walter S, Gießler W, Büntzel J. Tumor patients’ perceived changes of specific attitudes, perceptions, and behaviors due to the COVID-19 pandemic and its relation to reduced wellbeing. Front Psychiatry. 2020;11:574314. doi:10.3389/fpsyt.2020.574314.
   PubMed Web of Science ®Google Scholar
• Monto AS. The future of SARS-CoV-2 vaccination – lessons from influenza. N Engl J Med. 2021;385(20):1825–1827. doi:10.1056/NEJMp2113403.
   PubMed Web of Science ®Google Scholar